select trial semaglutide results Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design SELECT Cardiovascular Trial Information semaglutide select SELECT trial: Semaglutide

However, retatrutide is still an investigational medicine

10.1111/dme.13636 126 ahinK.ahintrkY.KkerG.zelik KkerG.BostanF.KkM.et al (2022)

significant or rapid elevation warrants investigation For patients with known or suspected fatty liver disease, a FIB-4 score (calculated from ALT, AST, age, and platelet count) can help stratify fibrosis risk non-invasively If gallstone risk is elevated particularly in rapid responders with significant early weight loss discuss whether ultrasound surveillance or ursodeoxycholic acid prophylaxis is appropriate Ask: "Do you have any concern about my liver function specifically, and should we track gallstone risk given how quickly I'm losing weight?" Question 8: Are There Any Vitamin or Nutrient Deficiencies I Should Watch For

Factores que determinan la duracin del uso de GLP-1 Varios factores clnicos y personales influyen en cunto tiempo un paciente debe continuar con terapia GLP-1